跳至主要内容
临床试验/NCT01734096
NCT01734096已完成4 期

Effect of Lower Body Negative Pressure and Angiotensin II Receptor Blockade on Renal Hemodynamic, Neuro-hormonal and Tubular Response in Pre-hypertensive States: a Randomized Controlled Trial.

PD Dr. Grégoire Wuerzner1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2009年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
78
试验地点
1
主要终点
sodium excretion

研究概览

简要总结

The purpose of this study is to determine whether in pre-hypertensive and hypertensive states such as white coat hypertension, obesity related hypertension or resistant hypertension, renal function is more sensitive to orthostatic stress.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI > 30 Kg/m2 (obesity group)
  • office BP >140/90 and daytime ambulatory blood pressure <135/85 (white coat hypertension group) _daytime abpm >135/85 mm Hg or nighttime abpm 120/70

排除标准

  • History of allergic reaction
  • Diabetes type 1 or type 2
  • History of renal artery stenosis
  • Acute illness

研究组 & 干预措施

control group

Active Comparator

healthy volunteer

干预措施: Lower body negative pressure (LBNP) (Other)

control group

Active Comparator

healthy volunteer

干预措施: Candesartan cilexetil (Drug)

obesity group

Active Comparator

Patients with BMI >30 Kg/m2

干预措施: Lower body negative pressure (LBNP) (Other)

obesity group

Active Comparator

Patients with BMI >30 Kg/m2

干预措施: Candesartan cilexetil (Drug)

white coat hypertension group

Active Comparator

Patients with office blood pressure >140/90 mmHg and ambulatory daytime blood pressure <135/85 mmHg

干预措施: Lower body negative pressure (LBNP) (Other)

white coat hypertension group

Active Comparator

Patients with office blood pressure >140/90 mmHg and ambulatory daytime blood pressure <135/85 mmHg

干预措施: Candesartan cilexetil (Drug)

Resistant hypertension

Active Comparator

Patients with ambulatory blood pressure > 135/85 mm Hg (day) or >120/70 mm Hg (night) with 3 antihypertensive drugs with direct observance of drug taking.

干预措施: Lower body negative pressure (LBNP) (Other)

结局指标

主要结局

sodium excretion

时间窗: after one hour of lower body negative pressure

sodium excretion will be compared to control group (healthy volunteers) after one hour of lower negative pressure. The protocol includes 2 hours of baseline measure, one hour of lower negative pressure and 2 hours of recovery

次要结局

  • glomerular filtration rate(after one hour of lower body negative pressure)

研究者

发起方
PD Dr. Grégoire Wuerzner
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

PD Dr. Grégoire Wuerzner

Doctord, MD, privat docent

Centre Hospitalier Universitaire Vaudois

研究点 (1)

Loading locations...

相似试验